Apart from GTG being cashed-up and ready to fast-track the B+ roll-out,
especially since most of the hard work & infrastructure has been layed-out with B1 over the last few yrs...
More good news with The Big Guns moving in on little GTG/GENE.
Canaccord Genuity via JPMorgan Chase: 7%
Capital Venture International: 9.70%
Sabby Healthcare Master Fund Ltd: 9.72%
The last 2 filed SEC form 13G's last Friday night.
"The number of Shares reported as beneficially owned consists of
166,666,650 Shares (represented by 1,111,111 American Depositary Shares)" each.
Both bought c/o service company's in the Caymans.
Nice...
Ref: www.nasdaq.com/symbol/gene/sec-filings
Wont be long
.
Apart from GTG being cashed-up and ready to fast-track the B+...
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
